The interview features comments on the emergence of T-cell engagers for therapy in patients with multiple myeloma made during the 2020 ASH Meeting & Exposition.
Jeffrey Wolf, MD
Advertisement
Articles by Jeffrey Wolf, MD
Wolf discusses the potential for emerging next-generation CAR T-cell treatment and the future of treating patients with multiple myeloma.
Advertisement
Latest Updated Articles
Jeffrey Wolf, MD, on Emerging T-Cell Engagers and Their Impact in Multiple MyelomaPublished: January 9th 2021 | Updated:
Jeffrey Wolf, MD, on Next-Generation CAR T Cell Therapy and the Future of Multiple Myeloma TreatmentsPublished: December 11th 2020 | Updated:
Advertisement
Advertisement
